88 related articles for article (PubMed ID: 3458956)
1. Rapidly reversible resistance to immune lysis of L5178Y lymphoma cells in a tumor-dormant state in DBA/2 mice.
Okayasu T; Wheelock EF
J Natl Cancer Inst; 1986 Jun; 76(6):1199-204. PubMed ID: 3458956
[TBL] [Abstract][Full Text] [Related]
2. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
3. Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.
Trainer DL; Wheelock EF
Cancer Res; 1984 Jul; 44(7):2897-906. PubMed ID: 6609767
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
Trainer DL; Wheelock EF
Cancer Res; 1984 Mar; 44(3):1063-71. PubMed ID: 6607108
[TBL] [Abstract][Full Text] [Related]
5. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
Robinson MK; Truitt GA; Okayasu T; Wheelock EF
Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383
[TBL] [Abstract][Full Text] [Related]
6. Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.
Marsili MA; Robinson MK; Truitt GA; Wheelock EF
Cancer Res; 1983 Jan; 43(1):15-21. PubMed ID: 6600159
[TBL] [Abstract][Full Text] [Related]
7. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
8. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
Lee FH; Currie D; Hwang KM
Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
[TBL] [Abstract][Full Text] [Related]
10. In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice.
Wheelock EF; Weinhold KJ; Ingenito GG; Goldstein LT
J Immunol; 1980 Apr; 124(4):1642-7. PubMed ID: 7365237
[No Abstract] [Full Text] [Related]
11. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
12. The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination.
Weinhold KJ; Miller DA; Wheelock EF
J Exp Med; 1979 Mar; 149(3):745-57. PubMed ID: 429962
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle assessment of adoptive transferred lymphokine activated killer cells.
Watanabe R; Tanaka N; Naomoto Y; Moreira LF; Orita K
Jpn J Clin Oncol; 1994 Apr; 24(2):59-65. PubMed ID: 8158860
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocytes in DBA/2 mice harboring L5178Y cells in a tumor-dormant state.
Marsili MA; Robinson MK; Truitt GA; Wheelock EF
Cancer Immunol Immunother; 1983; 16(1):59-64. PubMed ID: 6139161
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenicity of murine lymphomas selected through fluorescence-detected natural antibody binding.
Tough DF; Chow DA
Cancer Res; 1988 Jan; 48(2):270-5. PubMed ID: 3335005
[TBL] [Abstract][Full Text] [Related]
16. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells.
Müller M; Gounari F; Prifti S; Hacker HJ; Schirrmacher V; Khazaie K
Cancer Res; 1998 Dec; 58(23):5439-46. PubMed ID: 9850077
[TBL] [Abstract][Full Text] [Related]
17. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.
Robinson MK; Wheelock EF
J Immunol; 1981 Feb; 126(2):673-9. PubMed ID: 7451990
[No Abstract] [Full Text] [Related]
18. F1 resistance to AKR lymphoma cells in vivo and in vitro.
Schmitt-Verhulst A-M ; Zatz MM
J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
[TBL] [Abstract][Full Text] [Related]
19. The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice.
Weinhold KJ; Goldstein LT; Wheelock EF
J Exp Med; 1979 Mar; 149(3):732-44. PubMed ID: 311815
[TBL] [Abstract][Full Text] [Related]
20. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
